Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03178331Completed

Who Benefit From School Doctors' Health Checks?

Role: collaborator

NCT01742702Unknown

HaemoDYNAMICs in Primary and Secondary Hypertension

Role: collaborator

NCT01723852Not ApplicableCompleted

Vitamin D Intervention in Infants

Role: collaborator

NCT00668603Not ApplicableCompleted

Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)

Role: collaborator

NCT01015547Phase 3Completed

Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis

Role: collaborator

NCT00617838Not ApplicableUnknown

Celiac Disease Prevention

Role: collaborator

NCT00575835Not ApplicableCompleted

Oral Vitamin D Supplementation in Elderly Women

Role: collaborator

All 7 trials loaded